Public trial registry of the CCC-Munich

Trial AATT

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
AATT
World
Full title
:

Autologe oder allogene Transplantation
nach konventioneller Chemotherapie
bei jüngeren Patienten (18-60 Jahre)
mit reifem (peripherem) T-Zell-Lymphom
DSHNHL 2006-1A

World
Description
:

aus Sicherheitsgründen am 08.08.2014 Rekrutierung gestoppt

Eye
Primary endpoints
:

Eye
Secondary endpoints
:

World
EudraCT number
:
World
DRKS number
:
Unknown
World
NCT number
:
Unknown
World
ISRCTN number
:
Unknown
World
Responsible organization
:
Medizinische Klinik III, Telefon: 089440072551
Eye
Legal basis
:
AMG interventional
Eye
Registered by
:
MUELLER-MA15 ()
Indications
Classification Code Description
ICD-10-GM C84.- Reifzellige T/NK-Zell-Lymphome
- Bloodcancer (leukemia, lymphoma)
In-/Exclusion (Edit)
Eye
Criterion for Inclusion
:
Unknown
Eye
Criterion for exclusion
:
Unknown
Trial design
World
IIT (sponsored by KUM)
:
No
Eye
Sponsor status
:
Commercial
World
Trial type
:
Interventional
World
Blinding type
:
Open
World
Phase
:
III
Eye
Center design
:
Polycentric
Eye
Treatment arms count
:
Unknown
Eye
Sample size
:
0
Status
World
Status
:
Recruitment finished
Votes
World
Institutional review board - vote
:
Unknown
World
Institutional review board - reference number
:
World
PEI - vote
:
Unknown
World
PEI - reference number
:
World
BfArM - vote
:
Unknown
World
BfArM - reference number
:
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Recruitment
Eye
Time period (from / to)
:
Unknown / Unknown
Therapy
World
Therapy line
:
2
Eye
Therapy Category
:
World
Therapy
:

Tumorboards (Edit)
Eye
:
Dermatology Endocrinology Gastrointestinal
Gynecological Hematology KHT
Liver Lung Neurooncological
Pediatry Ortho. / Sarkoma Urological
Additionally involved centers (Edit)
Eye
:
Pharmacy Radiology
Institut für Labormedzin Transfusiology
Radiotherapy Nuclear medicine
Participants
Function Prename Surname Organization
World Principal Investigator MARTIN DREYLING Keine Organisationseinheit angegeben Magnifier
World Responsible contact Carmen Carlucci Keine Organisationseinheit angegeben Magnifier